Collegium Pharmaceutical Stock Price Transform Average Price

COLL Stock  USD 44.82  0.50  1.10%   
Collegium Pharmaceutical price transform tool provides the execution environment for running the Average Price transformation and other technical functions against Collegium Pharmaceutical. Collegium Pharmaceutical value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of price transform indicators. As with most other technical indicators, the Average Price transformation function is designed to identify and follow existing trends. Collegium Pharmaceutical price transformation methods enable investors to generate trading signals using basic price transformation functions such as typical price movement.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Collegium Pharmaceutical Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Collegium Pharmaceutical Technical Analysis Modules

Most technical analysis of Collegium Pharmaceutical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Collegium from various momentum indicators to cycle indicators. When you analyze Collegium charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Collegium Pharmaceutical Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Collegium Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Collegium Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Collegium Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Collegium Pharmaceutical's daily price indicators and compare them against related drivers, such as price transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Collegium Pharmaceutical's intrinsic value. In addition to deriving basic predictive indicators for Collegium Pharmaceutical, we also check how macroeconomic factors affect Collegium Pharmaceutical price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2025 2026 (projected)
Dividend Yield0.07480.0721
Price To Sales Ratio1.681.6
Hype
Prediction
LowEstimatedHigh
42.0444.8247.60
Details
Intrinsic
Valuation
LowRealHigh
40.3451.7054.48
Details
Naive
Forecast
LowNextHigh
43.1045.8848.66
Details
5 Analysts
Consensus
LowTargetHigh
48.3853.1759.02
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Collegium Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Collegium Pharmaceutical's short interest history, or implied volatility extrapolated from Collegium Pharmaceutical options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Strategy ETFs Idea
Strategy ETFs
Invested over 100 shares
Blockchain Idea
Blockchain
Invested over 90 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested over 30 shares
Macroaxis Index Idea
Macroaxis Index
Invested a lot of shares
Large Cap ETFs Idea
Large Cap ETFs
Invested over 500 shares
High Dividend Yield ETFs Idea
High Dividend Yield ETFs
Invested few shares
Disruptive Technologies Idea
Disruptive Technologies
Invested over 500 shares
Railroads Idea
Railroads
Invested few shares
Momentum Idea
Momentum
Invested over 100 shares
Adviser Favorites Idea
Adviser Favorites
Invested over 300 shares
When determining whether Collegium Pharmaceutical is a strong investment it is important to analyze Collegium Pharmaceutical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Collegium Pharmaceutical's future performance. For an informed investment choice regarding Collegium Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. Projected growth potential of Collegium fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Collegium Pharmaceutical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
2.132
Earnings Share
1.63
Revenue Per Share
23.798
Quarterly Revenue Growth
0.314
Return On Assets
0.0675
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Collegium Pharmaceutical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Collegium Pharmaceutical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Collegium Pharmaceutical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.